Search Results - "Blagden, M."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study by McCloskey, E., Rathi, J., Heijmans, S., Blagden, M., Cortet, B., Czerwinski, E., Hadji, P., Payer, J., Palmer, K., Stad, R., O’Kelly, J., Papapoulos, S.

    Published in Osteoporosis international (01-02-2021)
    “…Summary This study in 8 countries across Europe found that about 75% of elderly women seen in primary care who were at high risk of osteoporosis-related…”
    Get full text
    Journal Article
  2. 2

    Long‐term evaluation of combined prolonged‐release oxycodone and naloxone in patients with moderate‐to‐severe chronic pain: pooled analysis of extension phases of two Phase III trials by Blagden, M., Hafer, J., Duerr, H., Hopp, M., Bosse, B.

    Published in Neurogastroenterology and motility (01-12-2014)
    “…Background While opioids provide effective analgesia, opioid‐induced constipation (OIC) can severely impact quality of life and treatment compliance. This…”
    Get full text
    Journal Article
  3. 3

    Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease by Blagden, M. D., Chipperfield, R.

    Published in Current medical research and opinion (01-04-2007)
    “…ABSTRACT Objective: Combination of ezetimibe (EZE) with a statin represents an attractive strategy for cholesterol-lowering treatment, as it inhibits the two…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomised, double-blind, placebo-controlled study in UK general practice centres by Blagden, M, Christian, J, Miller, K, Charlesworth, A

    “…The flurbiprofen 8.75 mg lozenge is a novel formulation that combines a demulcent effect with the analgesic activity of a non-steroidal anti-inflammatory drug…”
    Get more information
    Journal Article
  7. 7

    Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial by Mancia, G, Cha, G, Gil-Extremera, B, Harvey, P, Lewin, A J, Villa, G, Kjeldsen, S E

    Published in Journal of human hypertension (01-03-2017)
    “…The DISTINCT study (reDefining Intervention with Studies Testing Innovative Nifedipine GITS—Candesartan Therapy) investigated the efficacy and safety of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    The changing scene of mine clearance by Blagden, P.M

    “…The slow and painstaking process of manual demining is a simple, standard process which seems to have survived almost unchanged since the 1940s. Now…”
    Get full text
    Conference Proceeding
  11. 11
  12. 12

    Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease by Blagden, M. D., Chipperfield, R.

    Published in Current Medical Research and Opinion (01-04-2007)
    “…Objective: Combination of ezetimibe (EZE) with a statin represents an attractive strategy for cholesterol-lowering treatment, as it inhibits the two main…”
    Get full text
    Report
  13. 13
  14. 14